1–3 of 3 results for Szilárd Kiss
Preclinical Evaluation of BGTF-027 (AAV.7m8-L-opsin), a Novel Intravitreal Gene Therapy for the Treatment of Blue Cone Monochromacy
Szilárd Kiss, MD
Annual Meeting Talks
2024
Interim Results and Key Learnings from an Ongoing Phase 2 Study of Encapsulated Cell Therapy Compared to Aflibercept in Patients With Wet AMD
2016
Subretinal Gene Therapy Delivery
Updates from the Field
2018